{
    "2021-03-25": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "arthritis",
                        "tanezumab",
                        "FDA",
                        "snag"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-04-20",
                "original_text": "U.S. stops distribution of Lilly's COVID-19 therapy due to impact of variants",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Lilly",
                        "COVID-19",
                        "therapy",
                        "variants"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-05-10",
                "original_text": "Global Life Sciences CDMO Selects Kneat's e-Validation SaaS Platform",
                "features": {
                    "keywords": [
                        "Global",
                        "Life Sciences",
                        "CDMO",
                        "Kneat",
                        "e-Validation",
                        "SaaS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}